Table of Contents

Executive Summary

1 Industry Overview of Human Vaccines

• 1.1 Definition of Human Vaccines
• 1.2 Human Vaccines Segment by Type
  • 1.2.1 Global Human Vaccines Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Varicella
  • 1.2.3 Influenza
  • 1.2.4 Polio
  • 1.2.5 Hepatitis A
  • 1.2.6 Rabies
  • 1.2.7 BCG
  • 1.2.8 Hepatitis B
  • 1.2.9 Other
• 1.3 Human Vaccines Segment by Applications
  • 1.3.1 Global Human Vaccines Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Adults
  • 1.3.3 Children
• 1.4 Global Human Vaccines Overall Market
  • 1.4.1 Global Human Vaccines Revenue (2014-2025)
  • 1.4.2 Global Human Vaccines Production (2014-2025)
  • 1.4.3 North America Human Vaccines Status and Prospect (2014-2025)
  • 1.4.4 Europe Human Vaccines Status and Prospect (2014-2025)
  • 1.4.5 China Human Vaccines Status and Prospect (2014-2025)
  • 1.4.6 Japan Human Vaccines Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Human Vaccines Status and Prospect (2014-2025)
  • 1.4.8 India Human Vaccines Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Human Vaccines
• 2.3 Manufacturing Process Analysis of Human Vaccines
• 2.4 Industry Chain Structure of Human Vaccines

3 Development and Manufacturing Plants Analysis of Human Vaccines

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Human Vaccines Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Human Vaccines
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Human Vaccines Production and Capacity Analysis
• 4.2 Human Vaccines Revenue Analysis
• 4.3 Human Vaccines Price Analysis
• 4.4 Market Concentration Degree

5 Human Vaccines Regional Market Analysis

• 5.1 Human Vaccines Production by Regions
  • 5.1.1 Global Human Vaccines Production by Regions
  • 5.1.2 Global Human Vaccines Revenue by Regions
• 5.2 Human Vaccines Consumption by Regions
• 5.3 North America Human Vaccines Market Analysis
  • 5.3.1 North America Human Vaccines Production
  • 5.3.2 North America Human Vaccines Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Human Vaccines Import and Export
• 5.4 Europe Human Vaccines Market Analysis
  • 5.4.1 Europe Human Vaccines Production
  • 5.4.2 Europe Human Vaccines Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Human Vaccines Import and Export
• 5.5 China Human Vaccines Market Analysis
  • 5.5.1 China Human Vaccines Production
  • 5.5.2 China Human Vaccines Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Human Vaccines Import and Export
• 5.6 Japan Human Vaccines Market Analysis
  • 5.6.1 Japan Human Vaccines Production
  • 5.6.2 Japan Human Vaccines Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Human Vaccines Import and Export
• 5.7 Southeast Asia Human Vaccines Market Analysis
  • 5.7.1 Southeast Asia Human Vaccines Production
  • 5.7.2 Southeast Asia Human Vaccines Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Human Vaccines Import and Export
• 5.8 India Human Vaccines Market Analysis
  • 5.8.1 India Human Vaccines Production
  • 5.8.2 India Human Vaccines Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Human Vaccines Import and Export

6 Human Vaccines Segment Market Analysis (by Type)

• 6.1 Global Human Vaccines Production by Type
• 6.2 Global Human Vaccines Revenue by Type
• 6.3 Human Vaccines Price by Type

7 Human Vaccines Segment Market Analysis (by Application)

• 7.1 Global Human Vaccines Consumption by Application
• 7.2 Global Human Vaccines Consumption Market Share by Application (2014-2019)

8 Human Vaccines Major Manufacturers Analysis

• 8.1 CNBG
  • 8.1.1 CNBG Human Vaccines Production Sites and Area Served
  • 8.1.2 CNBG Product Introduction, Application and Specification
  • 8.1.3 CNBG Human Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Changsheng Life
  • 8.2.1 Changsheng Life Human Vaccines Production Sites and Area Served
  • 8.2.2 Changsheng Life Product Introduction, Application and Specification
  • 8.2.3 Changsheng Life Human Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Zhifei
  • 8.3.1 Zhifei Human Vaccines Production Sites and Area Served
  • 8.3.2 Zhifei Product Introduction, Application and Specification
  • 8.3.3 Zhifei Human Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 ChengDa Bio
  • 8.4.1 ChengDa Bio Human Vaccines Production Sites and Area Served
  • 8.4.2 ChengDa Bio Product Introduction, Application and Specification
  • 8.4.3 ChengDa Bio Human Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Kangtai
  • 8.5.1 Kangtai Human Vaccines Production Sites and Area Served
  • 8.5.2 Kangtai Product Introduction, Application and Specification
  • 8.5.3 Kangtai Human Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 SINOVAC BIOTECH
  • 8.6.1 SINOVAC BIOTECH Human Vaccines Production Sites and Area Served
  • 8.6.2 SINOVAC BIOTECH Product Introduction, Application and Specification
  • 8.6.3 SINOVAC BIOTECH Human Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Hissen
  • 8.7.1 Hissen Human Vaccines Production Sites and Area Served
  • 8.7.2 Hissen Product Introduction, Application and Specification
  • 8.7.3 Hissen Human Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Walvax Biotechnology
  • 8.8.1 Walvax Biotechnology Human Vaccines Production Sites and Area Served
  • 8.8.2 Walvax Biotechnology Product Introduction, Application and Specification
  • 8.8.3 Walvax Biotechnology Human Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 GSK
  • 8.9.1 GSK Human Vaccines Production Sites and Area Served
  • 8.9.2 GSK Product Introduction, Application and Specification
  • 8.9.3 GSK Human Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 SANOFI
  • 8.10.1 SANOFI Human Vaccines Production Sites and Area Served
  • 8.10.2 SANOFI Product Introduction, Application and Specification
  • 8.10.3 SANOFI Human Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Rong An
• 8.12 NuoCheng Bio
• 8.13 Hualan Bio
• 8.14 Tiantan biological
• 8.15 Changchun Baike
• 8.16 Adimmune
• 8.17 Zhongyianke Biotech

9 Development Trend of Analysis of Human Vaccines Market

• 9.1 Global Human Vaccines Market Trend Analysis
  • 9.1.1 Global Human Vaccines Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Human Vaccines Regional Market Trend
  • 9.2.1 North America Human Vaccines Forecast 2019-2025
  • 9.2.2 Europe Human Vaccines Forecast 2019-2025
  • 9.2.3 China Human Vaccines Forecast 2019-2025
  • 9.2.4 Japan Human Vaccines Forecast 2019-2025
  • 9.2.5 Southeast Asia Human Vaccines Forecast 2019-2025
  • 9.2.6 India Human Vaccines Forecast 2019-2025
• 9.3 Human Vaccines Market Trend (Product Type)
• 9.4 Human Vaccines Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Human Vaccines Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

The global Human Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Human Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Vaccines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Human Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Human Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Other

Segment by Application
Adults
Children